AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in AbCellera Biologics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 203
- +15 vs. Q3 2022
- Shares held
- 127.9M
- +6.15M (+5.1%) vs. Q3 2022
- Total value
- $1.30B
- +$87.7M (+7.3%) vs. Q3 2022
- New holders
- 36
- 79 more added
- Sold out
- 21
- 58 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baillie Gifford & Co | 19,696,735 | $199.5M | 0.21% | +6,339,067+47.5% | Added |
| Coppell Advisory Solutions LLC | 348 | – | – | +348 | New |
| Coppell Advisory Solutions Corp. | 348 | – | – | +348 | New |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −327,619−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −230,400−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −224,102−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −162,885−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −160,643−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −154,325−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −96,417−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −84,143−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −79,799−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −68,657−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −57,430−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −36,525−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −34,838−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −34,516−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −31,293−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −16,509−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −11,999−100.0% | Sold out |
| Gryphon Financial Partners LLC | 0 | $0 | 0.00% | −10,490−100.0% | Sold out |
| Credential Qtrade Securities Inc. | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,080−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |